BD
Company Snapshot
Founded: 1897
Entity Type: Public
Employees: 72,000
Region: U.S.
Revenue: $21,840.0 Millions
Revenue Year: 2025
Segment: BD Life Sciences
Headquarter: New Jersey, U.S.
Key Geographics: Europe, Japan, Latin America, Asia-Pacific
Corporate Address: 1 becton drive, Franklin lakes, New Jersey 07417-1880 U.S. Tel. +1-201-847-6800 www.bd.com
Company Overview
Becton, Dickinson & Company (BD) offers medical devices, diagnostic products, and laboratory equipment for healthcare institutions, biopharmaceutical companies, life science research institutes, and clinical laboratories.
BD operates in three divisions: BD Medical, BD Life Sciences, and BD Interventional. BD Interventional provides vascular, urology, oncology, and surgical specialty products intended to be used once and then discarded or temporarily or permanently implanted. Under the peripheral intervention product line, BD offers biopsy devices for oncology diagnostics.
Financial Highlights (FY 2025)
Net Revenue: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
BD In News
Company's Business Segments
- Medical : Medication Delivery Solutions, Medication Management Solutions, Pharmaceutical Systems, and Advanced Patient Monitoring.
- Life Sciences : Integrated Diagnostic Solutions, and Biosciences
- Interventional : Surgery, Peripheral Intervention and Urology and Critical Care
Applications/End User Industries
- Clinical Laboratories
- Research Institutions
- Biopharmaceutical Companies
- Integrated Diagnostic Solutions
- Instruments Solutions
- Reagents Solutions
- Prefillable Drug Delivery Systems
- Self-Injection Systems
- Injectable Medications
- Administering Medications
- Surgical Centers
- Surgical Procedures
- Urology Clinics
- Critical Care Units
- Urological Procedures Interventions
- Urinary Drainage Interventions
- Critical Care Interventions
- Minimally Invasive Surgery
- Healthcare
- Medical Devices
- Biotechnology